<DOC>
	<DOC>NCT02813798</DOC>
	<brief_summary>The purpose of this study is to determine the effect of renal impairment on rivipansel.</brief_summary>
	<brief_title>A Study to Evaluate the Effect of IV Doses of Rivipansel on Subjects With Renal Impairment and in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Female subjects of nonchildbearing potential or male subjects Body Mass Index (BMI) of 17.5 to 40.0 kg/m2 Stable renal function A positive urine drug screen for illicit drugs Treatment with an investigational drug within 30 days of the dose of study medication Pregnant females, breastfeeding female subjects and male subjects with partners currently pregnant Use of herbal supplements in the 28 days prior to the dose of study medication Blood donation (excluding plasma donation) of approximately 1 pint or more within 56 days prior to study medication Requiring dialysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Renal Insufficiency</keyword>
</DOC>